Bioelectronics at SXSW
We are pursuing a new scientific field that could one day result in a novel class of medicines that would not be pills or injections, but miniaturized, implantable devices.
You may be wondering why a pharmaceutical company would attend a cutting-edge technology and digital festival like SXSW Interactive, which brings together the brightest minds in emerging technology. It’s simple: here at GSK, innovation is our business. For the past 150 years, we’ve been developing innovative medicines, vaccines and consumer healthcare products that are used by millions of people around the world.
And we aren’t slowing down. We continue to look at new ways to innovate in the healthcare space. At SXSW 2015, we presented our work on biosensors in partnership with McLaren. And at SXSW 2016, we presented our work on bioelectronic medicine in a session called Inner Space: Bioelectronics and Medicine's Future.
In the past 25 years, a steady increase in bacteria immune to antibiotics has become a serious threat to global public health
How we discover new medicines
Researching and developing a new medicine typically goes through several stages from laboratory to patient
Our relentless pursuit to discover and develop new medicines and vaccines